We also found that subsequent glutamine restoration produces cancer cells that substantially up-regulate the expression of the mCRPs CD59 and CD55 on the cell surface and that these glutamine-restored cancer cells are even more resistant to complement-mediated damage than unsynchronized breast cancer cells. The gene discussed is CD55; the disease is breast carcinoma.